Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Systematic screening identifies a 2‐gene signature as a high‐potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma

19 Nov 2019

Abstract excerpt

The Cancer Genome Atlas (TCGA) Research Network confirmed that undifferentiated pleomorphic sarcoma (UPS) and myxofibrosarcoma (MFS) share a high level of genomic similarities and fall into a single spectrum of tumour. However, no molecular prognostic biomarkers have been identified in UPS/MFS. In this study, by extracting data from TCGA-Sarcoma (SARC), we explored relapse-related genes, their prognostic value...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Sarcoma Diagnosis and Treatment
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31742892
DOI: 10.1111/jcmm.14814

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Systematic screening identifies a 2‐gene signature as a high‐potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcomaPMID 31742892Read ↗

Transcriptomic profiles of myxofibrosarcoma and undifferentiated pleomorphic sarcoma correlate with clinical and genomic features.Semantic proximity Read ↗

PDGFRA amplification could be a poor prognostic factor of advanced undifferentiated pleomorphic sarcoma in a comprehensive genomic profiling cohortSemantic proximity Read ↗

Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcomaSemantic proximity Read ↗

Heterogeneity of Undifferentiated Pleomorphic Sarcoma Genetic Landscape: Is There a Room for Targeted Therapy?Semantic proximity Read ↗

High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapiesSemantic proximity Read ↗

Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of boneSemantic proximity Read ↗

Pathogenic and Targetable Genetic Alterations in Resected Recurrent Undifferentiated Pleomorphic Sarcomas Identified by Targeted Next-generation SequencingSemantic proximity Read ↗

Histologic and Genetic Advances in Refining the Diagnosis of “Undifferentiated Pleomorphic Sarcoma”Semantic proximity Read ↗

Copy number gain of CMTM6 increases the expression of PD-L1 in undifferentiated pleomorphic sarcomaSemantic proximity Read ↗

Immune-related prognostic genes signatures in the tumor microenvironment of sarcomaSemantic proximity Read ↗

Single-cell sequencing reveals the landscape of the tumor microenvironment in a skeletal undifferentiated pleomorphic sarcoma patientSemantic proximity Read ↗

Novel pyroptosis-associated genes signature for predicting the prognosis of SarcomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.